Evidence map›Paper›PMID 32888389›Full record

ArticleJournal of cellular and molecular medicine2020

Functional variation of SLC52A3 rs13042395 predicts survival of Chinese gastric cancer patients.

Xiaofei Qu, Lei Cheng, Liqin Zhao, Lixin Qiu, Weijian Guo

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaofei QuDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.ORCID 0000-0002-6907-7490
Lei ChengDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Liqin ZhaoDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Lixin QiuDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Weijian GuoDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.ORCID 0000-0002-7500-428X
Shanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The solute carrier family 52 member 3 (SLC52A3) gene encodes riboflavin transporter protein which is essential to maintain mitochondrial function in cells. In our research, we found that SLC52A3 rs13042395 C > T variation was significantly associated with poor survival in a 926 Chinese gastric cancer (GCa) patients cohort (CC/CT genotype versus TT genotype, HR = 0.57, 95%CI (0.40-0.82), log-rank P = 0.015). The SLC52A3 rs13042395 C > T change led to its increased mRNA expression according to expression quantitative trait loci analysis (P = 0.0029). In vitro, it was revealed that rs13042395 C allele had higher binding affinity to inhibitory transcription factor Meis homeobox 1 (MEIS1) compared with T allele, knock-down of MEIS1 could up-regulate SLC52A3, and overexpression of SLC52A3 contributed to the increased ability of proliferation, colony formation, migration and invasion in GCa cells. Subsequently, the bioinformatics analysis combined with experiments in vitro suggested that Gap junction protein alpha 1 (GJA1) was the downstream effector of SLC52A3, SLC52A3 may promote the GCa cells aggressiveness by down-regulating the GJA1 expression. Overall, SLC52A3 genetic variant rs13042395 C > T change was associated with poorer survival in Chinese GCa patients and increased SLC52A3 expression by interaction with MEIS1. SLC52A3 promoted the GCa cells aggressiveness by down-regulating the GJA1 expression.

Indexed as

Genetic Predisposition to DiseaseAllelesAsian PeopleCell Line, TumorConnexin 43Down-RegulationEsophageal NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansMaleMembrane Transport ProteinsMiddle AgedMyeloid Ecotropic Viral Integration Site 1 ProteinPhenotypePolymorphism, Single NucleotideConnexin 43GJA1 protein, humanMEIS1 protein, humanMembrane Transport ProteinsMyeloid Ecotropic Viral Integration Site 1 ProteinRNA, MessengerSLC52A3 protein, humangastric cancerprognosissingle nucleotide polymorphismSLC52A3

Identifiers

PMID32888389
PMCPMC7686988
OpenAlexW3083312969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.